Category: Markets
-
BABA Stock Analysis: Alibaba Surges as AI Cloud Growth, Qwen and China Tech Rally Drive Revaluation
BABA Stock Analysis: Alibaba Surges as AI Cloud Growth, Qwen and China Tech Rally…
READ MORE: BABA Stock Analysis: Alibaba Surges as AI Cloud Growth, Qwen and China Tech Rally Drive RevaluationBY
-
AGIO Stock Analysis: Mitapivat FDA Priority Review, November 2026 PDUFA Date and the Sickle Cell Disease Opportunity
AGIO Stock Analysis: Mitapivat FDA Priority Review, November 2026 PDUFA Date and the Sickle…
READ MORE: AGIO Stock Analysis: Mitapivat FDA Priority Review, November 2026 PDUFA Date and the Sickle Cell Disease OpportunityBY
-
DOCN Stock Analysis: DigitalOcean’s AI-Native Cloud, 221% AI ARR Growth and the Intraday Reversal Risk
DOCN Stock Analysis: DigitalOcean’s AI-Native Cloud, 221% AI ARR Growth and the Intraday Reversal…
READ MORE: DOCN Stock Analysis: DigitalOcean’s AI-Native Cloud, 221% AI ARR Growth and the Intraday Reversal RiskBY
-
SEER Stock Analysis: Why Seer Is Surging After the $2.45 Buyout Proposal
SEER Stock Analysis: Why Seer Is Surging After the $2.45 Buyout Proposal Seer, Inc.…
READ MORE: SEER Stock Analysis: Why Seer Is Surging After the $2.45 Buyout ProposalBY
-
MRNA Stock Jumps on Moderna Flu Vaccine and Cancer Vaccine Data: Is the mRNA Platform Rebound Real?
Key Takeaways Moderna (NASDAQ: MRNA) jumped more than 10% as investors reassessed the company’s…
READ MORE: MRNA Stock Jumps on Moderna Flu Vaccine and Cancer Vaccine Data: Is the mRNA Platform Rebound Real?BY
-
DMRA Stock Rises on DMR-001 mutCALR Blood Cancer Pipeline: Is Damora Therapeutics a New MPN Biotech Play?
Key Takeaways Damora Therapeutics (NASDAQ: DMRA) rose as investors focused on the company’s DMR-001…
READ MORE: DMRA Stock Rises on DMR-001 mutCALR Blood Cancer Pipeline: Is Damora Therapeutics a New MPN Biotech Play?BY
-
CLRO Stock Explodes 101% on Cortigent Reverse Merger: Is ClearOne Becoming a Brain-Computer Interface Stock?
Key Takeaways ClearOne (NASDAQ: CLRO) surged more than 100% after announcing a merger agreement…
READ MORE: CLRO Stock Explodes 101% on Cortigent Reverse Merger: Is ClearOne Becoming a Brain-Computer Interface Stock?BY
-
FIG Stock Jumps After Figma Raises Guidance: Is This AI Design Platform Finally Rebounding After Its IPO Slump?
Key Takeaways Figma (NYSE: FIG) jumped after strong Q1 2026 earnings, faster revenue growth,…
READ MORE: FIG Stock Jumps After Figma Raises Guidance: Is This AI Design Platform Finally Rebounding After Its IPO Slump?BY
-
PLBL Stock Surges on 100MW Thailand AI Data Center MOU: AI Infrastructure Breakout or Low-Float Rally?
Key Takeaways Polibeli Group (NASDAQ: PLBL) surged after announcing a non-binding MOU to evaluate…
READ MORE: PLBL Stock Surges on 100MW Thailand AI Data Center MOU: AI Infrastructure Breakout or Low-Float Rally?BY
-
EDIT Stock Jumps on EDIT-401 CRISPR Data: Is Editas Medicine Becoming an In Vivo Gene Editing Comeback Play?
Key Takeaways Editas Medicine (NASDAQ: EDIT) moved sharply higher as investors focused on the…
READ MORE: EDIT Stock Jumps on EDIT-401 CRISPR Data: Is Editas Medicine Becoming an In Vivo Gene Editing Comeback Play?BY